Musely secures $360M from Common Catalyst with out giving up fairness

Musely, a direct-to-consumer telemedicine platform, has secured over $360 million in non-dilutive capital from Common Catalyst’s Buyer Worth Fund (CVF).

The corporate makes a speciality of compounded therapies for pores and skin, hair, and menopause care. Musely co-founder and CEO Jack Jia instructed TechCrunch that when CVF buyers reached out to him final yr, he wasn’t trying to increase capital.

That’s as a result of Musely, which was based in 2014 as a wellness neighborhood earlier than pivoting to prescription skincare in 2019, has been money circulate constructive for years, he mentioned. Jia didn’t need to cut back his possession within the firm by promoting off a piece of it to VCs. They steadily approached him a few potential spherical and he constantly turned them down, he mentioned.

However not like conventional enterprise capital, CVF wasn’t trying to take an fairness stake, nor was it providing a mortgage that might carry rate of interest prices. As a substitute, CVF’s different financing is just like a tiny revenue-share settlement: corporations with predictable income streams borrow capital, after which repay the funds together with a set, capped proportion of income it generates from using Common Catalyst’s fund

Though Jia was initially skeptical, he rapidly realized CVF’s phrases had been extra favorable than a regular financial institution mortgage and much less expensive than a dilutive fairness spherical.

“Once I mathematically modeled it, I discovered this totally compelling,” he mentioned.

Whereas Musely has been rising its income on common 50% year-over-year and has served over 1.2 million sufferers, buying new prospects for DTC manufacturers like Musely could be very pricey, Jia defined. “While you grow to be a billion-dollar income firm, you want one other billion to be able to develop to the following billion,” he mentioned. “That’s why many of the DTC corporations, in case you have a look at the capital burn, it’s big.”

The funding from CVF solves this downside, offering Musely with a capital battle chest to assist its buyer development. The funding will assist gross sales, advertising, and different buyer acquisition efforts.

Musely joins a CVF portfolio that features Grammarly, Lemonade, and Ro. The fund maintains its personal distinct restricted companions, and the capital it invests was not included in Common Catalyst’s final $8 billion fundraise.

Not like a lot of its friends, Musely has been remarkably capital-efficient. After elevating $20 million from DCM and different buyers in 2014, the corporate has not raised a single greenback of fairness capital since, based on Jia. Musely permits sufferers to entry prescription merchandise via asynchronous consultations with board-certified dermatologists and OB-GYNs.